跳至主要内容
临床试验/NL-OMON42263
NL-OMON42263招募中不适用

Metacognitive therapy vs. exposure and response prevention for obsessive-compulsive disorder: A randomized clinical trial. - metacognitive therapy vs. exposure and respons prevention for OCD.

PsyQ Rijnmond, onderdeel van parnassia bavo groep0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
90

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Primary diagnosis of obsessive-compulsive disorder, age between 18-65

排除标准

  • To enhance the clinical representativeness of the sample, exclusion criteria will be kept to a minimum. Patients are only excluded if they currently:
  • 1) meet DSM-V criteria for severe major depressive disorder that requires immediate treatment, psychotic disorder, or bipolar disorder
  • 2) have mental impairment or evidence of organic brain disorder
  • 3) have substance abuse requiring specialist treatment
  • 4) have a change in medication type or dose in the six weeks before assessment or during treatment.

研究者

发起方
PsyQ Rijnmond, onderdeel van parnassia bavo groep

相似试验

Metacognitive therapy vs. exposure and response... | 临床试验